Clinical Research Directory
Browse clinical research sites, groups, and studies.
Avr Thrombosis OutcoMe Study
Sponsor: East and North Hertfordshire NHS Trust
Summary
This study aims to utilise novel biomarkers assessing thrombosis and thrombolysis (through a blood test), to identify patients undergoing either surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) who are at risk of thrombosis, and relate this to clinical thrombotic and thromboembolic adverse events and subclinical valve thrombosis, and identify the timeframe of greatest risk for valve thrombosis.
Official title: Can Thrombosis and Fibrinolysis Markers in Patients Undergoing Aortic Valve Replacement Predict Outcome
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
750
Start Date
2020-02-01
Completion Date
2028-01
Last Updated
2020-01-21
Healthy Volunteers
No
Conditions
Interventions
Blood test
Blood test
Locations (1)
East and North Hertfordshire NHS Trust
Stevenage, Hertforshire, United Kingdom